ReviewJournal of clinical medicine2026
Dupilumab-Related Ocular Surface Disease in Atopic Dermatitis: Risk Stratification, Monitoring, and Persistence-Preserving Management.
Stefano Bighetti, Luca Bettolini, Carlo Alberto Maronese, Federica Macchi, Zeno Fratton, Vincenzo Maione, Mario Valenti, Giovanni Paolino, Andrea Carugno, Marco Ferrari and 4 more
Abstract readReview
In one paragraphReview in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Stefano BighettiDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0009-0006-2781-6909 Luca BettoliniDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0003-4374-802X Carlo Alberto MaroneseDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-9449-849X Federica MacchiDermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Zeno FrattonInstitute of Dermatology, Department of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-7454-1999 Vincenzo MaioneDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0002-0420-5009 Giovanni PaolinoDermatology Unit, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
Marco FerrariCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0002-2986-1272 Piergiacomo Calzavara-PintonDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0002-0935-7204 Marina VenturiniDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.ORCID 0000-0001-6800-3695 Nicola ZerbinatiDepartment of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy.ORCID 0000-0003-2177-9677 Mariateresa RossiDermatology Department, University of Brescia, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
atopic dermatitisconjunctivitisdrug survivaldupilumabdupilumab-associated ocular surface diseasemanagementocular surface diseaserisk stratification
Identifiers
PMID41753336
PMCPMC12942636
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390